Volume 12, Issue 4 (2-2021)
2021, 12(4): 55-65 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
khataminia M, Sahebnasagh A, Najmeddin F, Najafi A, Negarandeh R, Mojtahedzadeh M. Treatment of Anemia, Blood Transfusion and Its Substitutes in Intensive Care Uniteʾs (ICU) Patients: A Review Based on Current Evidence. North Khorasan University of Medical Sciences 2021; 12 (4) :55-65
URL: http://journal.nkums.ac.ir/article-1-2218-en.html
URL: http://journal.nkums.ac.ir/article-1-2218-en.html
Masoud Khataminia1 
, Adeleh Sahebnasagh2 
, Farhad Najmeddin3 , Atabak Najafi4 , Reza Negarandeh5 , Mojtaba Mojtahedzadeh * 6
, Adeleh Sahebnasagh2 , Farhad Najmeddin3 , Atabak Najafi4 , Reza Negarandeh5 , Mojtaba Mojtahedzadeh * 6
1- Student Research Committee, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
2- Clinical Research Center, Department of Internal Medicine, Faculty of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran
3- Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
4- Department of Anesthesiology and Critical Care Medicine, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
5- Student research committee, Department of pharmaceutics, Faculty of pharmacy, Mazandaran university of medical sciences, Sari, Iran
6- Department of Clinical Pharmacy, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran , mojtahed@tums.ac.ir
2- Clinical Research Center, Department of Internal Medicine, Faculty of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran
3- Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
4- Department of Anesthesiology and Critical Care Medicine, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
5- Student research committee, Department of pharmaceutics, Faculty of pharmacy, Mazandaran university of medical sciences, Sari, Iran
6- Department of Clinical Pharmacy, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran , mojtahed@tums.ac.ir
Abstract: (2963 Views)
Introduction: Anemia in critically ill patients is common and affects their outcome. Treatment of anemia in ICUʾs patients have some challenges. Red blood cells transfusion is associated with some serious adverse effects which further affects patient’s outcome. In this article, the etiology of the anemia in critically ill and its management strategies is reviewed.
Methods: This study was done to summarize findings from earlier evidence on the prevalence and effect of anemia in critically ill patients on their outcome. We searched in medical data sources of PubMed, Scopus and Google Scholar using the following keywords: anemia OR erythropoietin, OR red blood cell, OR transfusion, AND critical illness, OR intensive care. After reviewing title and abstracts, all clinical studies conducted on this group of patients were included.
Results: In most studies, the evidence supports restrictive protocol of RBC transfusion (transfusion at Hb < 7 g/dL) preferably over a liberal transfusion strategy (transfusion at Hb < 10 g/dL), in ICU patients. Only those with acute cardiovascular disease or early stages of severe sepsis may benefit from higher threshold of 9-10g/dL for blood preparation transfusion.
Conclusions: The occurrence of anemia is common in critically ill patients. Considering its multifactorial etiology, it has a negative effect on patients’ outcome. Blood transfusions are associated with some serious adverse effects, such as Acute respiratory distress syndrome and infections. The potential risk benefit must be carefully evaluated in every patient for whom a blood transfusion is being considered.
Methods: This study was done to summarize findings from earlier evidence on the prevalence and effect of anemia in critically ill patients on their outcome. We searched in medical data sources of PubMed, Scopus and Google Scholar using the following keywords: anemia OR erythropoietin, OR red blood cell, OR transfusion, AND critical illness, OR intensive care. After reviewing title and abstracts, all clinical studies conducted on this group of patients were included.
Results: In most studies, the evidence supports restrictive protocol of RBC transfusion (transfusion at Hb < 7 g/dL) preferably over a liberal transfusion strategy (transfusion at Hb < 10 g/dL), in ICU patients. Only those with acute cardiovascular disease or early stages of severe sepsis may benefit from higher threshold of 9-10g/dL for blood preparation transfusion.
Conclusions: The occurrence of anemia is common in critically ill patients. Considering its multifactorial etiology, it has a negative effect on patients’ outcome. Blood transfusions are associated with some serious adverse effects, such as Acute respiratory distress syndrome and infections. The potential risk benefit must be carefully evaluated in every patient for whom a blood transfusion is being considered.
Type of Study: Review Article |
Subject:
Basic Sciences
Received: 2020/01/20 | Accepted: 2020/11/8 | Published: 2021/02/28
Received: 2020/01/20 | Accepted: 2020/11/8 | Published: 2021/02/28
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
